Consensus ORPEA London S.E.

Equities

0NEX

FR0000184798

Market Closed - London S.E. Other stock markets 09:00:00 03/06/2024 pm IST			After market 11:09:09 pm
13.9 ^EUR	+8.17%		13.9	+0.01%

15/05	ORPEA : Challenging recovery in France, adequate elsewhere
15/05	Oddo BHF Upgrades Emeis to Neutral from Underperform, Lifts PT	MT

Evolution of the average Target Price on ORPEA

Price target over the last 5 years

History of analyst recommendation changes

b7bb2eb4288bbca115062.NJCXXavX09SfrkpvZv1ReoWb_mrkFMk88UTJMbOU0cc.fvOmGcadoYX91Bg1KcsOTLPMrxCGLPtWlzWrVsXzlLNn8cAx7rqlmPn5KQ~ab8ac52d590015501e4c9742570fc41a

Analyst Recommendations on ORPEA

ORPEA : Challenging recovery in France, adequate elsewhere	15/05
Oddo BHF Upgrades Emeis to Neutral from Underperform, Lifts PT	15/05	MT
EMEIS : Oddo BHF raises its opinion	15/05	CF
ORPEA : Partial integration of the FY23 results	23/04
ORPEA : Ready for a refoundation full of thorns	19/04
ORPEA : Allowing for the 1,000-to-1 reverse stock split	22/03
ORPEA : Recaps now completed, yet the costly and timely rebuild continues	16/02
ORPEA : Target cut by -11.5%	16/02
Oddo BHF Cuts Orpea PT, Keeps Underperform Opinion	16/02	MT
ORPEA : Oddo BHF maintains 'underperform' rating, reduces target	16/02	CF
ORPEA : A 1,000-to-1 reverse stock split is scheduled to be effective 22 March	05/02
ORPEA : Target cut by -9.6%	19/01
ORPEA : Another unsuccessful Board overhaul following the completion of the second planned recap	22/12
ORPEA : Allowing for the second planned capital increase	18/12
ORPEA : Allowing for the first planned capital increase	01/12
Oddo BHF Maintains Orpea at Underperform, Reduces PT	15/11	MT
ORPEA : Oddo BHF keeps its distance from the stock and reduces its target price	15/11	CF
ORPEA : Gloomier light at the end of the tunnel	08/11
ORPEA : When poor(er) results are no longer news	16/23/16
ORPEA : Oddo BHF maintains 'underperform' rating	31/23/31	CF
ORPEA : Integrating the 2022 annual report information	27/23/27
ORPEA : Good-looking organic growth amidst a bleak outlook	27/23/27
ORPEA : Integrating the 2,500x dilution	25/23/25
ORPEA : AlphaValue reduces its target further	17/23/17	CF
ORPEA : Allowing for the profit warning	17/23/17